神经血管共病与并发症对破裂颅内动脉瘤术后结局的影响:第二部分
基于2012-2015年美国全国住院患者样本库,纳入5353例蛛网膜下腔出血后接受颅内动脉瘤手术/介入治疗的患者,评估神经血管共病指数(NCI)与院内并发症对功能结局、死亡率、住院时长和费用的影响。结果显示NCI越高,任何并发症、癫痫、内科并发症、外科并发症和脑血管痉挛的风险越高,功能结局越差、死亡率越高、住院时间越长、费用越高。
要点
- NCI每升高与并发症风险增加相关,NCI=7时内科并发症OR达2.50。
- NCI较高者功能结局(mRS等效)更差,NCI=7时OR为1.95。
- 院内并发症在中等共病负担患者中影响更大。
核心结论
- 神经血管共病是破裂颅内动脉瘤术后功能结局差、院内死亡、住院时间延长和费用增加的主要驱动因素。
研究设计与样本
- 回顾性队列研究,查询2012-2015年美国全国住院患者样本库(NIS),纳入5353例蛛网膜下腔出血后接受颅内动脉瘤治疗的患者。
- 使用国际疾病分类第九版(ICD-9)编码识别病例,聚合神经血管共病指数(NCI),并以NIS-蛛网膜下腔出血严重程度评分(NIS-SSS)作为Hunt-Hess分级的替代指标。
主要发现
- NCI中位数为4.00(四分位距0.00-7.00),2882例(54%)发生院内并发症。
- NCI较高与任何并发症(NCI=1时OR 1.13,NCI=7时OR 2.05,P<0.001)、癫痫(OR 1.11至1.60)、内科并发症(OR 1.18至2.50)、外科并发症(OR 1.13至1.91)和脑血管痉挛(OR 1.09至1.49)风险增加相关。
- NCI较高与功能结局(mRS等效)差相关(NCI=1时OR 1.06,NCI=7时OR 1.95,P<0.001),院内并发症亦与功能结局差相关(P<0.001)。
- 院内死亡、住院时间和费用呈现类似趋势。
临床怎么用
- 对破裂颅内动脉瘤患者应评估神经血管共病负担,高NCI提示术后并发症和不良结局风险增高。
- 关注中等共病负担患者,因其受并发症影响更为显著。
局限性
- 基于行政数据库的回顾性研究,可能存在编码偏倚和混杂因素。
- NIS-SSS作为Hunt-Hess分级的替代指标,非直接临床分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aim to define the dynamic interplay between neurovascular-specific comorbidities and in-hospital complications on outcomes (functional outcome and mortality), length of stay (LOS), and cost of hospital stay. METHODS: The 2012-2015 National Inpatient Sample (NIS) was queried for intracranial aneurysm treatment after subarachnoid hemorrhage using International Classification of Diseases, Ninth Revision codes. Neurovascular comorbidity index (NCI) was aggregated. NIS-Subarachnoid Hemorrhage Severity Score (NIS-SSS) was used as a Hunt-Hess grade proxy. In-hospital complications were medical complications, surgical complications, seizures, and cerebral vasospasm. Outcomes were functional outcome (modified Rankin Scale [mRS]-equivalent measure), in-hospital mortality, LOS, and cost. Multivariable logistic regression models were built for mRS equivalent and in-hospital mortality. Multivariable linear regression models in log scale were built for LOS and cost. RESULTS: A total of 5353 patients were included. The median NCI was 4.00 (interquartile range [IQR], 0.00-7.00) and 2882 patients (54%) had in-hospital complication. Higher NCI (odds ratio [OR], 1.13 if NCI = 1; OR, 2.05 if NCI = 7; P < 0.001) was associated with any complication, seizure (OR, 1.11, NCI = 1; OR, 1.60, NCI = 7; P < 0.001), medical complication (OR, 1.18, NCI = 1; OR, 2.50, NCI = 7; P < 0.001), surgical complication (OR, 1.13, NCI = 1; OR, 1.91, NCI = 7; P < 0.001), and cerebral vasospasm (OR, 1.09, NCI = 1; OR, 1.49, NCI = 7; P < 0.001). Patients with higher NCI (OR, 1.06, NCI = 1; OR, 1.95, NCI = 7; P < 0.001) or with in-hospital complication (P < 0.001) had poorer mRS equivalent outcome. Similar trends were observed for other outcomes including in-hospital mortality, LOS, and cost. CONCLUSIONS: Neurovascular comorbidities are the primary driver of poor mRS equivalent outcome, in-hospital mortality, higher LOS, and higher cost after ruptured intracranial aneurysm procedural treatment. The conditional event of complication influences patients with moderate comorbidities more so than those with low or high comorbidities.
引用
- Chotai S, Patel PD, Liles C, et al. Impact of Neurovascular Comorbidities and Complications on Outcomes After Procedural Management of Intracranial Aneurysm: Part 2, Ruptured Intracranial Aneurysm. World Neurosurg. 2020. PMID: 33470214. doi:10.1016/j.wneu.2020.10.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。